Indeed, in all patients tested, the addition of four HRR genes brought about a very small uplift in the potential causes of HRD in BRCA1/2 wild type/GIS-positive tumours, with only 2/35 additional pathogenic variants identified. Here, BRCA1 is linked to neoplasm.